| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 05/31/2006 | EP1163238B1 Chemokine recpetor binding heterocyclic compounds |
| 05/31/2006 | EP1090136B1 Mumbaistatin, a process for its production and its use as a pharmaceutical |
| 05/31/2006 | EP0946501B1 Prevention of loss and restoration of bone mass by certain prostaglandin agonists |
| 05/31/2006 | EP0891426B1 Human bikunin |
| 05/31/2006 | EP0885228B1 Meso-substituted tripyrrane compounds, compositions, and methods for making and using the same |
| 05/31/2006 | CN1780911A Human antihuman interleukin-18 antibody, fragment thereof and method of using the same |
| 05/31/2006 | CN1780840A Pyrazolo 1,5-a pyrimidine derivatives |
| 05/31/2006 | CN1780819A 4,4-difluoro-1,2,3,4-tetrahydro-5h-1-benzoazepine derivative or salt of the same |
| 05/31/2006 | CN1780816A 2-hydroxynicotianamine, process for producing the same and angiotensin converting enzyme inhibitor, hypotensive drug and health food |
| 05/31/2006 | CN1780636A Combined use of G-CSF with angiogenetic factor |
| 05/31/2006 | CN1780621A Sulfonamide derivatives as gamma secretase inhibitors. |
| 05/31/2006 | CN1780615A The use of azetidinecarboxamide derivatives in therapy. |
| 05/31/2006 | CN1778387A Health-care products for improving anamnesis and preventing brain function catagenesis and its preparation thereof |
| 05/31/2006 | CN1778381A Chinese medicine for against depressive disorders and hypothermia |
| 05/31/2006 | CN1778324A Effective part of nightshadeleaf ironweed for antiscolic medicines and its preparation and use |
| 05/31/2006 | CN1778294A Butin and its derivative and its use in preparation of pigmental metabolic disease medicine |
| 05/31/2006 | CN1257986C The method of detecting mutant DSPP gene of hereditary opalescent dentin |
| 05/31/2006 | CN1257966C Wine-making method using medlar and young pigeon |
| 05/31/2006 | CN1257917C Process for preparing collagen active polypeptide from avian animal tissue |
| 05/31/2006 | CN1257905C Compounds for inhibiting the release of inflammatory cytokines |
| 05/31/2006 | CN1257894C Phenylethenyl or phenylethinyl derivatives as glutamate receptor antagonists |
| 05/31/2006 | CN1257892C New indole derivatives with 5-HT6 receptor affinity |
| 05/31/2006 | CN1257891C Nitrogenous five-membered ring compounds |
| 05/31/2006 | CN1257889C Novel amino acid derivatives, method for production thereof and pharmaceutical compositions comprising said derivative |
| 05/31/2006 | CN1257886C Dehydroamino acids compounds |
| 05/30/2006 | US7053245 N-acylamino benzyl ether derivatives |
| 05/30/2006 | US7053219 such as 5-methyl-6-(4-methoxyphenyl)-3-pyridin-4-yl-isoxazolo[4,5-c]pyridin-4(5H)one which has metabotropic glutamic acid receptor-antagonistic effect; for treatment of anxiety disorders, psychosomatic disorders, and eating disorders |
| 05/30/2006 | US7053215 For therapy of inflammatory and immunoregulatory disorders and diseases, such as multiple sclerosis, rheumatoid arthritis and type I diabetes |
| 05/30/2006 | US7053214 Tryptase inhibitor; antiinflammatory agents |
| 05/30/2006 | US7053213 Therapeutic heterocycles |
| 05/30/2006 | US7053117 Substituted 4H-chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 05/30/2006 | US7053113 Mannich base prodrugs of 3-(pyrrol-2-yl-methylidene)-2-indolinone derivatives |
| 05/30/2006 | US7053111 Autoimmune disease; organ transplanting; controlling cell proliferation, cell differentiation |
| 05/30/2006 | US7053108 Indoline compounds |
| 05/30/2006 | US7053105 Farnesyl transferase inhibiting quinoline and quinazoline derivatives as farnesyl transferase inhibitors |
| 05/30/2006 | US7053103 A pyrazolo[3,4-B]pyridine derivatives; corticotropin releasing factor receptor antagonists; treating stress-related illnesses, mood disorders, eating disorders, stress-induced gastrointestinal dysfunctions, neurodegenerative diseases, and neuropsychiatric disorders |
| 05/30/2006 | US7053101 Orphan opioid receptor (orl-1) ligands; anxiety, depression, neuropathic and acute pain, migraines, asthma, improved cognition |
| 05/30/2006 | US7053098 3,4-Dihydro-(1H) quinazolin-2-one compounds as CSBP/P38 kinase inhibitors |
| 05/30/2006 | US7053093 Nitrogen compounds such as 1-((3- Phenylimidazo(5,1-a)-isoquinolin-6-yl)carbonyl)piperidine, that bind preferentially to gamma-aminobutyric acid (GABAA) receptors; prophylaxis of nervous system disorders |
| 05/30/2006 | US7053090 Antiinflammatory agents; antihistamines; skin disorders; antiarthritic agents; antidiabetic agents; autoimmune disease |
| 05/30/2006 | US7053086 For cancer therapy |
| 05/30/2006 | US7053084 Antagonist for preventing the deposits of amyloid protein, for treating neurodegenerative disease, Alzheimer's disease and Down's Syndrome; (2R,3S) N1-[1,3-dihydro-1-methyl-2-oxo-5-phenyl-2H-1,4-benzodiazepin-3-yl]-2-(2-methylpropyl)-3-allyl-butanediamide |
| 05/30/2006 | US7053081 Cyclic malonamides as inhibitors of A-β protein production |
| 05/30/2006 | US7053072 Methods for the administration of amifostine and related compounds |
| 05/30/2006 | US7053071 Induction of apoptosis in cancer cells |
| 05/30/2006 | US7053060 Glucopyranosyloxybenzylbenzene derivatives, medicinal compositions containing the same and intermediates in the production thereof |
| 05/30/2006 | US7053057 Caspase inhibitors and uses thereof |
| 05/30/2006 | US7053056 Antiinflammatory agents; autoimmune disease; antiischemic agents |
| 05/30/2006 | US7053055 Compounds of unstable DP IV-inhibitors |
| 05/30/2006 | US7053050 administering erythropoietin receptor antagonist or mimetics thereof |
| 05/30/2006 | US7053049 Cardiovascular disorders; anticholesterol agents; administering apolipoproteins and phospholipids mixture |
| 05/30/2006 | US7053045 Isolated human nuclear hormone receptors, nucleic acid molecules encoding human nuclear hormone receptors, and uses thereof |
| 05/30/2006 | US7053044 Artificial peptides having surface activity and the use thereof in the preparation of artificial surfactant |
| 05/30/2006 | US7052903 Compositions and methods for activating genes of interest |
| 05/30/2006 | US7052896 Lactobacillus rhamnosus polynucleotides, polypeptides and methods for using them |
| 05/30/2006 | US7052895 nucleotide sequences that code amino acid sequences having hydrolase enzyme activity, used for medical diagnosis, for prophylaxis of diseases and drug screening; bioassay |
| 05/30/2006 | US7052860 Identification of Actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring of periodontal diseases |
| 05/30/2006 | US7052850 Isolated human EDG-4 receptor |
| 05/30/2006 | US7052714 Ophthalmic adhesive preparations for percutaneous adsorption |
| 05/30/2006 | US7052684 Methods of healing wounds and fibrotic disorders using IL-10 |
| 05/30/2006 | US7052680 aerosols containing antiparkinsons drugs benzotropine, pergolide, amantadine, deprenyl and ropinerole, that have been heated on a solid support such as foil and condensed by passing through a flow of air |
| 05/30/2006 | US7052679 thin film of drugs; heating; dispensing as aerosol condensation |
| 05/30/2006 | CA2413235C Processing method of lactonization in the preparation of statins |
| 05/30/2006 | CA2375908C Highly selective norepinephrine reuptake inhibitors and methods of using the same |
| 05/30/2006 | CA2354605C Diazabicyclooctane derivatives and therapeutic uses thereof |
| 05/30/2006 | CA2345582C Process for the preparation of the mesylate salt trihydrate of 1-(4-hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperidin-1-yl)-1-propanol |
| 05/30/2006 | CA2237594C Fused imidazole derivatives as multidrug resistance modulators |
| 05/30/2006 | CA2200220C Drug for tumor growth suppression |
| 05/30/2006 | CA2157668C Tricyclic 2,3,4,5-tetrahydro-1h-3-benzazepines, their use and preparation |
| 05/30/2006 | CA2117377C Substituted amino alkyl compounds |
| 05/26/2006 | WO2006055747A2 Bis(thio-hydrazide amides) for increasing hsp70 expression |
| 05/26/2006 | WO2006055597A1 Use of ribose-cysteine to treat hypoxia by enhancing delivery of glutathione and atp levels in cells |
| 05/26/2006 | WO2006054793A1 Benzofuran compound and pharmaceutical composition containing the same |
| 05/26/2006 | WO2006054773A1 Activation of caspase in the cell division stage of cancer cells and utilization of caspase inhibitor in anticancer agent and so on |
| 05/26/2006 | WO2006054770A1 Novel map kinase kinase kinase (mapkkk) |
| 05/26/2006 | WO2006054757A1 Caspase inhibitor |
| 05/26/2006 | WO2006054629A1 1-SUBSTITUTED-3-β-D-GLUCOPYRANOSYLATED NITROGENOUS HETERO- CYCLIC COMPOUNDS AND MEDICINES CONTAINING THE SAME |
| 05/26/2006 | WO2006054560A1 Aromatic amide derivatives, medicinal compositions containing the same, medical uses of both |
| 05/26/2006 | WO2006054536A1 Therapeutic agent for urolithiasis |
| 05/26/2006 | WO2006054456A1 Crystal of two-ring heterocyclic sulfonamide compound |
| 05/26/2006 | WO2006054396A1 Cyclic isodityrosine derivatives |
| 05/26/2006 | WO2006054119A1 Topical formulations for use in the treatment or prevention of dermatological conditions |
| 05/26/2006 | WO2006054059A1 Neutralising antibody molecules having specificity for human il-17 |
| 05/26/2006 | WO2006053555A2 Pyrazol-3-one and/or pyridazin-3-one derivatives used as inhibitors of lysyl oxidase |
| 05/26/2006 | WO2006034446A3 Pyridine derivatives for inhibiting human stearoyl-coa-desaturase |
| 05/26/2006 | WO2006006079A3 Methods for suppressing neovascularization using ephrinb2 |
| 05/26/2006 | WO2005099769A3 Novel g-csf conjugates |
| 05/26/2006 | CA2588963A1 1-substituted-3-.beta.-d-glucopyranosylated nitrogenous hetero-cyclic compounds and medicines containing the same |
| 05/26/2006 | CA2588768A1 Aromatic amide derivatives, medicinal compositions containing the same, medical uses of both |
| 05/26/2006 | CA2587616A1 Use of ribose-cysteine to treat hypoxia by enhancing delivery of glutathione and atp levels in cells |
| 05/26/2006 | CA2587598A1 Bis(thio-hydrazide amides) for increasing hsp70 expression |
| 05/26/2006 | CA2584222A1 Neutralising antibody molecules having specificity for human il-17 |
| 05/25/2006 | US20060111569 Thiazolopyrimidines and their use as modulators of chemokine receptor activity |
| 05/25/2006 | US20060111567 Nonpeptide substituted spirobenzoazepines as vasopressin antagonists |
| 05/25/2006 | US20060111562 Human SDF-5 protein and compositions |
| 05/25/2006 | US20060111446 5-Amidino-N-(2-aminophenethyl)-2-hydroxybenzenesulfonamide derivative, medicinal composition containing the same, pharmaceutical use thereof, and intermediate therefor |
| 05/25/2006 | US20060111426 Indole-3-sulphur derivaties |
| 05/25/2006 | US20060111425 To treat diseases of respiratory, urinary and gastrointestinal systems; highly selective; significant potency; (2R,2S)(1 alpha ,5 alpha ,6 alpha )-N-{-[4-(1,3-dioxo-1,3-dihydro-isoindol-2-yl)-butyl]-3-azabicyclo[3.1.0]hex-6-yl-methyl}-2-hydroxy-2-cyclopentyl-2-phenylacetamide |
| 05/25/2006 | US20060111419 Novel fused indazole compounds |
| 05/25/2006 | US20060111418 Blood-brain barrier disruption inhibitor |